Beta Bionics (BBNX) Asset Utilization Ratio (2025 - 2026)
Beta Bionics (BBNX) posted Asset Utilization Ratio of 0.4 for Q2 2026, up 14.54% sequentially from 0.35 in Q1 2026, and up 70.73% YoY from 0.23 in Q2 2025.
Beta Bionics (BBNX) Asset Utilization Ratio (2025 - 2026) Analysis & Trends
Beta Bionics has reported Asset Utilization Ratio for 2 years, with the latest figure at 0.4 in Q2 2026.
- Quarterly Asset Utilization Ratio rose 70.73% year-over-year to 0.4 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.4 (up 70.73% YoY) and the FY2025 annual result came in at 0.42, down 16.44% from the prior year.
- Asset Utilization Ratio grew to 0.4 in Q2 2026 per BBNX's latest filing, from 0.35 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.4 in Q2 2026 and troughed at 0.23 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 0.42 |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 0.55 |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 0.47 |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 0.48 |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 0.76 |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 0.57 |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 0.80 |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 0.56 |
| 10 | Beta Bionics | 842.80 Mn | 662.31 Mn | 18.90 Mn | 0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.40 |
| Mar 31, 2026 | 0.35 |
| Dec 31, 2025 | 0.30 |
| Sep 30, 2025 | 0.27 |
| Jun 30, 2025 | 0.23 |
| Mar 31, 2025 | 0.29 |